Structure–Activity Relationships and Molecular Pharmacology of Positive Allosteric Modulators of the Mu-Opioid Receptor
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.4c00541 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Mengchu Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Edward F Domino Research Center, Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109, United States. Hauptthemen laut MEDLINE: Receptors, Opioid, mu, Analgesics, Opioid. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.
Abstract (Originalsprache)
Positive allosteric modulation of the mu-opioid receptor is a promising strategy to address the ever-growing problem of acute and chronic pain management. Positive allosteric modulators (PAMs) of the mu-opioid receptor could be employed to enhance the efficacy of endogenous opioid peptides to a degree that provides pain relief without the need for traditional opioid drugs. Alternatively, PAMs might be used to enhance the action of opioid drugs and so provide an opioid-sparing effect, allowing for the use of lower doses of opioid agonists and potentially decreasing associated side effects. BMS-986122 (2-(3-bromo-4-methoxyphenyl)-3-[(4-chlorophenyl)-sulfonyl]-thiazolidine) has been previously identified as a PAM of the mu-opioid receptor. In the present work, we have designed and synthesized 33 analogs of BMS-986122 to explore the structure-activity relationships of this scaffold and confirm its allosteric mechanism of action. Among several newly identified modulators, the most promising compound (14b) had improved activity to increase the in vitro potency of the standard mu-opioid agonist DAMGO and showed in vivo activity in mice to enhance the antinociceptive action of morphine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Edward F Domino Research Center, Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109, United States.
- Vahlteich Medicinal Chemistry Core, University of Michigan, Ann Arbor, Michigan 48109, United States.
- Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States.
ORCID-Profile: Mengchu Li, Andrew D White
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
Zitieren
APA
Li, M., Gan, X., Liu, K., Rajeswaran, W. G., Stanczyk, M. A., Stewart, H. C., Rech, J. C., White, A. D., & Traynor, J. R. (2025). Structure–Activity Relationships and Molecular Pharmacology of Positive Allosteric Modulators of the Mu-Opioid Receptor. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00541
Vancouver
Li M, Gan X, Liu K, Rajeswaran WG, Stanczyk MA, Stewart HC, et al. Structure–Activity Relationships and Molecular Pharmacology of Positive Allosteric Modulators of the Mu-Opioid Receptor. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.4c00541
BibTeX
@article{Li2025,
author = {Li, Mengchu and Gan, Xinmin and Liu, Kun and Rajeswaran, Walajapet G and Stanczyk, M Alex and Stewart, Hannah C and Rech, Jason C and White, Andrew D and Traynor, John R},
title = {Structure–Activity Relationships and Molecular Pharmacology of Positive Allosteric Modulators of the Mu-Opioid Receptor},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.4c00541}
}
EUVIMED